AstraZeneca PLC is 61.6x more valuable than INDIVIOR PLC by market capitalization ($286.27 B vs $4.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INDV | AZN |
|---|---|---|
| Market cap | $4.64 B | $286.27 B |
| US-listed rank | #1451 | #45 |
| Revenue (latest FY) | $1.24B | - |
| Net income (latest FY) | $210.00M | - |
| Net margin | 16.9% | - |
| P/E (trailing FY) | 22.1 | - |
| SEC filings | 513 | 1,004 |
AstraZeneca PLC is 61.6x more valuable than INDIVIOR PLC by market capitalization ($286.27 B vs $4.64 B).
Full pages: INDIVIOR PLC and AstraZeneca PLC, or browse the full rankings.